| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
REVIEW |
1 Institut Català d'Oncologia, Servei d'Epidemiologia i Registre del Càncer, Gran Via Km 2.7 s/n 08907 L'Hospitalet de Llobregat, 08907 Barcelona, Spain
2 Digene Corporation, 1201 Clopper Road, Gaithersburg, MD 20878, USA
3 International Agency for Research on Cancer (IARC), Unit of Field and Intervention Studies, 150 Cours Albert-Thomas, F-69372 Lyon, Cedex 08, France
4 Vrije Universiteit Medical Center, Department of Pathology, De Boelelaan 1117, PO Box 7057–1007, 1081 HV Amsterdam, The Netherlands
5 The John Hopkins School of Public Health, Department of Molecular Microbiology and Immunology, 615 North Wolfe Street, Baltimore, MD 21205, USA
Correspondence to:
Dr F X Bosch, Epidemiology and Cancer Registry Unit (SERC), Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Gran Via km 2,7, L'Hospitalet de Llobregat, 08907 Barcelona, Spain;
x.bosch{at}ico.scs.es
ABSTRACT
The causal role of human papillomavirus infections in cervical cancer has been documented beyond reasonable doubt. The association is present in virtually all cervical cancer cases worldwide. It is the right time for medical societies and public health regulators to consider this evidence and to define its preventive and clinical implications. A comprehensive review of key studies and results is presented.
Keywords: human papillomavirus; cervical cancer; causality; review
Abbreviations: AF, attributable fraction; ASCUS, atypical squamous cells of undetermined significance; CI, confidence interval; CIN, cervical intraepithelial neoplasia; EBV, Epstein-Barr virus; GP, general primer; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HPV, human papillomavirus; HSIL, high grade squamous intraepithelial lesion; HSV-2; type 2 herpes simplex virus; IARC, International Agency for Research on Cancer; IBSCC, international biological study on cervical cancer; OC, oral contraceptive; OR, odds ratio; ORF, open reading frame; Pap, Papanicolaou; PF, protective fraction; PCR, polymerase chain reaction; RB, retinoblastoma; RR, relative risk; STD, sexually transmitted disease; Th1, T helper cell type 1
This article has been cited by other articles:
|
|
 |
|
  J. Koshiol, L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, and J. S. Smith Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis Am. J. Epidemiol., May 15, 2008; (2008) kwn036v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Andrae, L. Kemetli, P. Sparen, L. Silfverdal, B. Strander, W. Ryd, J. Dillner, and S. Tornberg Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden J Natl Cancer Inst, May 7, 2008; 100(9): 622 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sabol, M. Salakova, J. Smahelova, M. Pawlita, M. Schmitt, N. M. Gasperov, M. Grce, and R. Tachezy Evaluation of Different Techniques for Identification of Human Papillomavirus Types of Low Prevalence J. Clin. Microbiol., May 1, 2008; 46(5): 1606 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Bian, Y. Wang, Z. Lu, Z. Ye, L. Zhao, J. Ren, H. Zhang, L. Ruan, and H. Tian Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice Mol. Cancer Ther., May 1, 2008; 7(5): 1329 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Z. A. Mbulawa, A.-L. Williamson, D. Stewart, J.-A. S. Passmore, L. Denny, B. Allan, and D. J. Marais Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease J. Gen. Virol., April 1, 2008; 89(4): 910 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A.V. Boulet, C. A.J. Horvath, S. Berghmans, and J. Bogers Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 810 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. K. Cheung, T. H. Cheung, J. W. T. Tang, and P. K. S. Chan Increase of Integration Events and Infection Loads of Human Papillomavirus Type 52 with Lesion Severity from Low-Grade Cervical Lesion to Invasive Cancer J. Clin. Microbiol., April 1, 2008; 46(4): 1356 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M F Evans, C S.-C. Adamson, and K Cooper Evidence of HPV16 integration in low- and high-grade cervical lesions that regress demonstrated by multiple displacement amplification and Southern blot hybridisation J. Clin. Pathol., April 1, 2008; 61(4): 541 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zheng, H. Ding, Z. Lu, Y. Li, Y. Pan, T. Ning, and Y. Ke E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. Genes Cells, March 1, 2008; 13(3): 285 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y P Bao, N Li, J S Smith, and Y L Qiao Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis Int J STD AIDS, February 1, 2008; 19(2): 106 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Syrjanen, I. Shabalova, N. Petrovichev, V. Kozachenko, T. Zakharova, J. Pajanidi, J. Podistov, G. Chemeris, L. Sozaeva, E. Lipova, et al. Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia Int J STD AIDS, January 1, 2008; 19(1): 16 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lehtovirta, J. Paavonen, and O. Heikinheimo Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women Int J STD AIDS, January 1, 2008; 19(1): 37 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J.P. Welters, G. G. Kenter, S. J. Piersma, A. P.G. Vloon, M. J.G. Lowik, D. M.A. Berends-van der Meer, J. W. Drijfhout, A. R. P.M. Valentijn, A. R. Wafelman, J. Oostendorp, et al. Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine Clin. Cancer Res., January 1, 2008; 14(1): 178 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Horvath, G Boulet, S Sahebali, J Bogers, C Depuydt, A Vereecken, T Vermeulen, and D Vanden Broeck Effects of fixation on RNA integrity in a liquid-based cervical cytology setting J. Clin. Pathol., January 1, 2008; 61(1): 132 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ressler, R. Scheiden, K. Dreier, A. Laich, E. Muller-Holzner, H. Pircher, D. Morandell, I. Stein, H.-P. Viertler, F. R. Santer, et al. High-risk Human Papillomavirus E7 Oncoprotein Detection in Cervical Squamous Cell Carcinoma Clin. Cancer Res., December 1, 2007; 13(23): 7067 - 7072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Seresini, M. Origoni, F. Lillo, L. Caputo, A. M. Paganoni, S. Vantini, R. Longhi, G. Taccagni, A. Ferrari, C. Doglioni, et al. IFN-{gamma} Produced by Human Papilloma Virus-18 E6-Specific CD4+ T Cells Predicts the Clinical Outcome after Surgery in Patients with High-Grade Cervical Lesions J. Immunol., November 15, 2007; 179(10): 7176 - 7183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, K. Elfgren, T. Radberg, B. Strander, O. Forslund, B.-G. Hansson, et al. Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer N. Engl. J. Med., October 18, 2007; 357(16): 1589 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jeronimo, L. S. Massad, P. E. Castle, S. Wacholder, M. Schiffman, and for the National Institutes of Health (NIH) Americ Interobserver Agreement in the Evaluation of Digitized Cervical Images Obstet. Gynecol., October 1, 2007; 110(4): 833 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fraillery, D. Baud, S. Y.-Y. Pang, J. Schiller, M. Bobst, N. Zosso, F. Ponci, and D. Nardelli-Haefliger Salmonella enterica Serovar Typhi Ty21a Expressing Human Papillomavirus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever Clin. Vaccine Immunol., October 1, 2007; 14(10): 1285 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Berraondo, C. Nouze, X. Preville, D. Ladant, and C. Leclerc Eradication of Large Tumors in Mice by a Tritherapy Targeting the Innate, Adaptive, and Regulatory Components of the Immune System Cancer Res., September 15, 2007; 67(18): 8847 - 8855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Day, C. D. Thompson, C. B. Buck, Y.-Y. S. Pang, D. R. Lowy, and J. T. Schiller Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of Inhibition J. Virol., August 15, 2007; 81(16): 8784 - 8792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shrestha, C. Wang, B. Aissani, C. M. Wilson, J. Tang, and R. A. Kaslow Interleukin-10 Gene (IL10) Polymorphisms and Human Papillomavirus Clearance among Immunosuppressed Adolescents Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1626 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G A V Boulet, I Schrauwen, S Sahebali, C Horvath, C E Depuydt, A Vereecken, D V. Broeck, E A Van Marck, and J J Bogers Correlation between laminin-5 immunohistochemistry and human papillomavirus status in squamous cervical carcinoma J. Clin. Pathol., August 1, 2007; 60(8): 896 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kim, K. M. Kuntz, N. K. Stout, S. Mahmud, L. L. Villa, E. L. Franco, and S. J. Goldie Multiparameter Calibration of a Natural History Model of Cervical Cancer Am. J. Epidemiol., July 15, 2007; 166(2): 137 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stevens, S. M. Garland, E. Rudland, J. Tan, M. A. Quinn, and S. N. Tabrizi Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results J. Clin. Microbiol., July 1, 2007; 45(7): 2130 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Garland, M. Hernandez-Avila, C. M. Wheeler, G. Perez, D. M. Harper, S. Leodolter, G. W.K. Tang, D. G. Ferris, M. Steben, J. Bryan, et al. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases N. Engl. J. Med., May 10, 2007; 356(19): 1928 - 1943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Waller, L A V Marlow, and J Wardle The association between knowledge of HPV and feelings of stigma, shame and anxiety Sex. Transm. Inf., April 1, 2007; 83(2): 155 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shai, T. Brake, C. Somoza, and P. F. Lambert The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent Activities Cancer Res., February 15, 2007; 67(4): 1626 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.C.R. Ragin, F. Modugno, and S.M. Gollin The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus J. Dent. Res., February 1, 2007; 86(2): 104 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Kwan, C. Metayer, V. Crouse, and P. A. Buffler Maternal Illness and Drug/Medication Use during the Period Surrounding Pregnancy and Risk of Childhood Leukemia among Offspring Am. J. Epidemiol., January 1, 2007; 165(1): 27 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Mejia, T. D. Culp, N. M. Cladel, K. K. Balogh, L. R. Budgeon, C. B. Buck, and N. D. Christensen Preclinical Model To Test Human Papillomavirus Virus (HPV) Capsid Vaccines In Vivo Using Infectious HPV/Cottontail Rabbit Papillomavirus Chimeric Papillomavirus Particles J. Virol., December 15, 2006; 80(24): 12393 - 12397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fakhry, G. D'souza, E. Sugar, K. Weber, E. Goshu, H. Minkoff, R. Wright, E. Seaberg, and M. Gillison Relationship between Prevalent Oral and Cervical Human Papillomavirus Infections in Human Immunodeficiency Virus-Positive and -Negative Women J. Clin. Microbiol., December 1, 2006; 44(12): 4479 - 4485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lipke An Armamentarium of Wart Treatments Clin. Med. Res., December 1, 2006; 4(4): 273 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Engelmark, E. L. Ivansson, J. J. Magnusson, I. M. Gustavsson, A. H. Beskow, P. K.E. Magnusson, and U. B. Gyllensten Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs Hum. Mol. Genet., November 15, 2006; 15(22): 3351 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Han, D. C. Swan, S. J. Smith, S. H. Lum, S. E. Sefers, E. R. Unger, and Y.-W. Tang Simultaneous Amplification and Identification of 25 Human Papillomavirus Types with Templex Technology J. Clin. Microbiol., November 1, 2006; 44(11): 4157 - 4162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Schiller and D. R. Lowy Prospects for Cervical Cancer Prevention by Human Papillomavirus Vaccination Cancer Res., November 1, 2006; 66(21): 10229 - 10232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N W J Bulkmans, S Bulk, M S Ottevanger, L Rozendaal, S M Hellenberg, F J van Kemenade, P J F Snijders, A J P Boeke, and C J L M Meijer Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate J. Clin. Pathol., November 1, 2006; 59(11): 1218 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Hesselink, N. W. J. Bulkmans, J. Berkhof, A. T. Lorincz, C. J. L. M. Meijer, and P. J. F. Snijders Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening Program. J. Clin. Microbiol., October 1, 2006; 44(10): 3680 - 3685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J P A Baak, A-J Kruse, S J Robboy, E A M Janssen, B van Diermen, and I Skaland Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers J. Clin. Pathol., October 1, 2006; 59(10): 1017 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Poulin and J. A. DeCaprio Is There a Role for SV40 in Human Cancer? J. Clin. Oncol., September 10, 2006; 24(26): 4356 - 4365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M Leung, P. P S Woo, S. M McGhee, A. N Y Cheung, S. Fan, O. Mang, T. Q Thach, and H. Y S Ngan Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods. J. Epidemiol. Community Health, August 1, 2006; 60(8): 712 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Irwin, D. Montano, D. Kasprzyk, L. Carlin, C. Freeman, R. Barnes, N. Jain, J. Christian, and C. Wolters Cervical Cancer Screening, Abnormal Cytology Management, and Counseling Practices in the United States Obstet. Gynecol., August 1, 2006; 108(2): 397 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Dasbach, E. H. Elbasha, and R. P. Insinga Mathematical Models for Predicting the Epidemiologic and Economic Impact of Vaccination against Human Papillomavirus Infection and Disease Epidemiol. Rev., August 1, 2006; 28(1): 88 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Koshiol, J. Schroeder, D. J. Jamieson, S. W. Marshall, A. Duerr, C. M. Heilig, K. V. Shah, R. S. Klein, S. Cu-Uvin, P. Schuman, et al. Smoking and Time to Clearance of Human Papillomavirus Infection in HIV-Seropositive and HIV-Seronegative Women Am. J. Epidemiol., July 15, 2006; 164(2): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stevens, E. Rudland, S. M. Garland, and S. N. Tabrizi Assessment of MagNA Pure LC Extraction System for Detection of Human Papillomavirus (HPV) DNA in PreservCyt Samples by the Roche AMPLICOR and LINEAR ARRAY HPV Tests. J. Clin. Microbiol., July 1, 2006; 44(7): 2428 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hiller, S. Poppelreuther, F. Stubenrauch, and T. Iftner Comparative Analysis of 19 Genital Human Papillomavirus Types with Regard to p53 Degradation, Immortalization, Phylogeny, and Epidemiologic Risk Classification. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1262 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Trottier, S. Mahmud, M. C. Costa, J. P. Sobrinho, E. Duarte-Franco, T. E. Rohan, A. Ferenczy, L. L. Villa, and E. L. Franco Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1274 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Coutlee, D. Rouleau, P. Petignat, G. Ghattas, J. R. Kornegay, P. Schlag, S. Boyle, C. Hankins, S. Vezina, P. Cote, et al. Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test. J. Clin. Microbiol., June 1, 2006; 44(6): 1998 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Silverberg, M. F. Schneider, B. Silver, K. M. Anastos, R. D. Burk, H. Minkoff, J. Palefsky, A. M. Levine, and R. P. Viscidi Serological Detection of Human Papillomavirus Type 16 Infection in Human Immunodeficiency Virus (HIV)-Positive and High-Risk HIV-Negative Women Clin. Vaccine Immunol., April 1, 2006; 13(4): 511 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Lowy Human Papillomaviruses: What They Are and What They Do Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 275 - 278. [Full Text] [PDF]
|
|
|
|
 |
|
 I. de Melo-Martin The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection. Oncologist, April 1, 2006; 11(4): 393 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Burchell, H. Richardson, S. M. Mahmud, H. Trottier, P. P. Tellier, J. Hanley, F. Coutlee, and E. L. Franco Modeling the Sexual Transmissibility of Human Papillomavirus Infection using Stochastic Computer Simulation and Empirical Data from a Cohort Study of Young Women in Montreal, Canada Am. J. Epidemiol., March 15, 2006; 163(6): 534 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Castellsague, M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, S. Franceschi, R. W. Peeling, R. Ashley, J. S. Smith, P. J. F. Snijders, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst, March 1, 2006; 98(5): 303 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 |
